Academic Tech Transfer Collaboration Required for Pharma R&D Model

A new market research report is focusing on the need for a new pharmaceutical research and development model with academic tech transfer collaboration for the future of drug innovation. It goes on to state that  growing emphasis on academic and non-profit organization partnerships could rescue the pharmaceutical industry from the redundancy of an insufficient R&D model and fill the supposed "innovation gap". The report in question is "PharmaSphere: Early-Stage Technology Transfer Collaborations - Enabling Platform Technologies & Deal Synergies Between Academix and the Pharmaceutical Industry." Read the full story.